08.01.2014 Views

DM Full Guideline (2010) - VA/DoD Clinical Practice Guidelines Home

DM Full Guideline (2010) - VA/DoD Clinical Practice Guidelines Home

DM Full Guideline (2010) - VA/DoD Clinical Practice Guidelines Home

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Version 4.0<br />

B. Refer To Pediatric Diabetes Management<br />

OBJECTIVE<br />

<strong>VA</strong>/<strong>DoD</strong> <strong>Clinical</strong> <strong>Practice</strong> <strong>Guideline</strong><br />

for the Management of Diabetes Mellitus<br />

Provide appropriate management for children with diabetes.<br />

BACKGROUND<br />

Approximately three-fourths of all newly diagnosed cases of type 1 <strong>DM</strong> occur in children (below the age of 18).<br />

Children’s healthcare needs are different from those of adults in several ways. Providing healthcare to children not<br />

only must involve meeting their physical needs, but must address their changing developmental stages.<br />

RECOMMENDATIONS<br />

1. Children with diabetes should be referred for consultative care to a pediatric diabetic team that is<br />

knowledgeable and experienced in meeting the medical, psychosocial, and developmental needs of children<br />

with diabetes.<br />

2. The pediatric diabetic team should include a pediatric endocrinologist, if available, and/or a pediatrician,<br />

certified diabetes educator, registered nurse, registered dietitian, and social worker, all with expertise and<br />

specialized training in the comprehensive care of children with diabetes.<br />

C. Is Patient A Female of Reproductive Potential?<br />

OBJECTIVE<br />

Assess the risk of maternal and fetal complications of an unintended pregnancy and implement prevention strategies.<br />

BACKGROUND<br />

The risk of fetal congenital anomalies is directly related to the periconceptual HbA 1 c values. The major determinant<br />

of outcome is the degree of maternal glycemic control before and during pregnancy.<br />

RECOMMENDATIONS<br />

1. All female patients with pre-existing diabetes and reproductive potential should be educated about<br />

contraceptive options, and strongly encouraged to plan and prepare for pregnancy, and to optimize their<br />

glycemic control prior to attempting to conceive.<br />

2. Women with diabetes who are planning pregnancy should be educated about the different options of<br />

diabetes management during the pregnancy and referred to maternal fetal medicine provider before, or as<br />

early as possible, once pregnancy is confirmed.<br />

3. Women with gestational diabetes mellitus (G<strong>DM</strong>) should be screened for diabetes 6-12 weeks postpartum<br />

and should follow-up with subsequent screening for diabetes or prediabetes (See Module S: Screening)<br />

For management of diabetes during pregnancy – see <strong>VA</strong>/DOD clinical practice guideline for the management of<br />

pregnancy. (www.healthquality.va.gov or https://www.qmo.amedd.army.mil)<br />

DISCUSSION<br />

Because of the high-risk nature of a diabetic pregnancy and the need for intensive multidisciplinary monitoring and<br />

patient support, referral of women with diabetes to an expert high-risk perinatal team at the earliest possible<br />

opportunity must be considered as the standard of care. Ideally, such a referral should be made during the period of<br />

planned conception.<br />

Nondiabetic pregnancies with maternal HbA 1 c levels below 7.0 mg/dL translate into a 1 to 2 percent risk of fetal<br />

anomalies. For diabetic pregnancies, maternal levels of HbA 1 c above 11 percent result in anomalies in 25 percent of<br />

these pregnancies.<br />

Module D: Core Page 15

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!